director, intellectual property
Serge Ilin-Schneider is an intellectual property and regulatory counsel with Par Pharmaceutical, a division of Endo International plc – a global specialty pharmaceutical company. Based in Chestnut Ridge, New York, Ilin-Schneider provides support on a wide range of intellectual property and regulatory matters/issues across Company’s US operations, specializing in product development strategy, complex issues with FDA, patent portfolio management, business development, and product lifecycle management. Prior to joining Par, Ilin-Schneider worked as an associate at Fox Rothschild, Locke Lord and Morgan & Finnegan, where his practice was primarily centered around counseling, patent portfolio management, patent prosecution, freedom to operate analysis, licensing, due diligence, domestic/foreign oppositions, and patent litigation. Ilin-Schneider holds an undergraduate degree from Rensselaer, a law degree from Seton Hall, and a PhD from MIT.